37902124|t|Functional variants of the chitinase 3-like 1 gene are associated with clinicopathologic outcomes and progression of prostate cancer.
37902124|a|Chitinase 3-like 1 (CHI3L1 or YKL40) is a secreted glycoprotein highly expressed in advanced stages of several cancer types, including prostate cancer (PCa). Impacts of genetic variants of CHI3L1 on PCa development have not yet been investigated. The most common well-studied genetic variations are single-nucleotide polymorphisms (SNPs). Therefore, the objective of this study was to explore associations of CHI3L1 SNPs with both the susceptibility to PCa and its clinicopathological development. Three promoter SNPs, rs6691378 (-1371, G>A), rs10399805 (-247, G>A) and rs4950928 (-131, C>G), and one non-synonymous SNP, rs880633 (+2950, T>C), were analysed using a TaqMan allelic discrimination assay for genotyping in a cohort of 701 PCa patients and 701 healthy controls. Results indicated that there were no significant associations of PCa susceptibility with these four CHI3L1 SNPs. However, among elderly PCa patients (aged >65 years), it was observed that polymorphic variants (GA + AA) of CHI3L1 rs6691378 and 10399805 were significantly linked to reduced risks of several clinicopathological characteristics, including a high Gleason grade, advanced pathologic T stage and tumour cell invasion. Moreover, analyses of The Cancer Genome Atlas database revealed that CHI3L1 expression levels were elevated in PCa tissues compared with normal tissues. Interestingly, higher CHI3L1 expression levels were found to be associated with longer progression-free survival rates in PCa patients. Our findings indicated that levels of CHI3L1 may influence the progression of PCa, and the rs6691378 and 10399805 SNP genetic variants of CHI3L1 are linked to the clinicopathological development of PCa within a Taiwanese population.
37902124	27	45	chitinase 3-like 1	Gene	1116
37902124	117	132	prostate cancer	Disease	MESH:D011471
37902124	134	152	Chitinase 3-like 1	Gene	1116
37902124	154	160	CHI3L1	Gene	1116
37902124	164	169	YKL40	Gene	1116
37902124	245	251	cancer	Disease	MESH:D009369
37902124	269	284	prostate cancer	Disease	MESH:D011471
37902124	286	289	PCa	Disease	MESH:D011471
37902124	323	329	CHI3L1	Gene	1116
37902124	333	336	PCa	Disease	MESH:D011471
37902124	543	549	CHI3L1	Gene	1116
37902124	587	590	PCa	Disease	MESH:D011471
37902124	653	662	rs6691378	SNP	tmVar:rs6691378;VariantGroup:0;CorrespondingGene:1116;RS#:6691378;CorrespondingSpecies:9606
37902124	664	674	-1371, G>A	DNAMutation	tmVar:c|SUB|G|-1371|A;HGVS:c.-1371G>A;VariantGroup:0;CorrespondingGene:1116;RS#:6691378;CorrespondingSpecies:9606;CA#:10912383
37902124	677	687	rs10399805	SNP	tmVar:rs10399805;VariantGroup:1;CorrespondingGene:1116;RS#:10399805;CorrespondingSpecies:9606
37902124	689	698	-247, G>A	DNAMutation	tmVar:c|SUB|G|-247|A;HGVS:c.-247G>A;VariantGroup:1;CorrespondingGene:1116;RS#:10399805;CorrespondingSpecies:9606;CA#:10889446
37902124	704	713	rs4950928	SNP	tmVar:rs4950928;VariantGroup:2;CorrespondingGene:1116;RS#:4950928;CorrespondingSpecies:9606
37902124	715	724	-131, C>G	DNAMutation	tmVar:c|SUB|C|-131|G;HGVS:c.-131C>G;VariantGroup:2;CorrespondingGene:1116;RS#:4950928;CorrespondingSpecies:9606;CA#:10575499
37902124	755	763	rs880633	SNP	tmVar:rs880633;VariantGroup:3;CorrespondingGene:1116;RS#:880633;CorrespondingSpecies:9606
37902124	765	775	+2950, T>C	DNAMutation	tmVar:c|SUB|T|+2950|C;HGVS:c.+2950T>C;VariantGroup:3;CorrespondingGene:1116;RS#:880633;CorrespondingSpecies:9606;CA#:1339303
37902124	870	873	PCa	Disease	MESH:D011471
37902124	974	977	PCa	Disease	MESH:D011471
37902124	1009	1015	CHI3L1	Gene	1116
37902124	1045	1048	PCa	Disease	MESH:D011471
37902124	1131	1137	CHI3L1	Gene	1116
37902124	1138	1147	rs6691378	SNP	tmVar:rs6691378;VariantGroup:0;CorrespondingGene:1116;RS#:6691378;CorrespondingSpecies:9606
37902124	1316	1322	tumour	Disease	MESH:D009369
37902124	1364	1370	Cancer	Disease	MESH:D009369
37902124	1407	1413	CHI3L1	Gene	1116
37902124	1449	1452	PCa	Disease	MESH:D011471
37902124	1513	1519	CHI3L1	Gene	1116
37902124	1613	1616	PCa	Disease	MESH:D011471
37902124	1665	1671	CHI3L1	Gene	1116
37902124	1705	1708	PCa	Disease	MESH:D011471
37902124	1718	1727	rs6691378	SNP	tmVar:rs6691378;VariantGroup:0;CorrespondingGene:1116;RS#:6691378;CorrespondingSpecies:9606
37902124	1765	1771	CHI3L1	Gene	1116
37902124	1825	1828	PCa	Disease	MESH:D011471
37902124	Negative_Correlation	MESH:D011471	RS#:6691378;CorrespondingGene:1116
37902124	Association	RS#:4950928;HGVS:c.-131C>G;CorrespondingGene:1116	MESH:D011471
37902124	Association	RS#:880633;HGVS:c.+2950T>C;CorrespondingGene:1116	MESH:D011471
37902124	Association	MESH:D011471	RS#:4950928;CorrespondingGene:1116
37902124	Association	RS#:10399805;CorrespondingGene:1116	MESH:D011471
37902124	Association	RS#:6691378;HGVS:c.-1371G>A;CorrespondingGene:1116	MESH:D011471
37902124	Association	MESH:D011471	1116
37902124	Association	MESH:D011471	RS#:880633;CorrespondingGene:1116
37902124	Association	RS#:880633;CorrespondingGene:1116	MESH:D011471
37902124	Association	RS#:10399805;HGVS:c.-247G>A;CorrespondingGene:1116	MESH:D011471
37902124	Association	MESH:D009369	1116
37902124	Association	RS#:4950928;CorrespondingGene:1116	MESH:D011471
37902124	Association	MESH:D011471	RS#:10399805;CorrespondingGene:1116
37902124	Association	MESH:D011471	1116

